| Gene symbol | CD33 | Synonyms | CD33rSiglec, SIGLEC-3, SIGLEC3, p67 | Type of gene | protein-coding |
| Chromosome | 19 | Map location | 19q13.41 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | ||||
| Description | CD33 molecule | ||||
| GTO ID | GTC1617 |
| Trial ID | NCT02799680 |
| Disease | Acute Myeloid Leukemia |
| Altered gene | CD33 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD33 CAR-T cells |
| Phase | Phase1 |
| Recruitment status | Unknown |
| Title | Allogeneic CART-33 for Relapsed/Refractory CD33+ AML |
| Year | 2015 |
| Country | China |
| Company sponsor | The Affiliated Hospital of the Chinese Academy of Military Medical Sciences |
| Other ID(s) | CART-AML-2015 |
| Cohort 1 | |||||||||
|
|||||||||